Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $76.49 | $17.10 | 347.31% | 318.71x | 22.27x | 23.37x | 62.65x | 1.57x | $41.15M | 0.61% | $108.58M | 1.23 | $6.76B | 126.20 | ||
| CORT | CORCEPT THERAPEUTICS INC | $90.47 | $23.38 | 286.95% | 196.67x | 151.62x | 12.29x | 15.22x | 1.40x | $119.79M | 1.27% | $637.99M | 6.11 | $9.61B | -1,400.09 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.28 | $2.73 | 202.90% | 118.29x | 72.70x | 4.49x | 109.87x | 1.13x | $47.52M | 3.37% | $13.01M | 0.08 | $1.58B | 29.50 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $281.26 | $90.25 | 211.65% | 64.51x | 37.55x | 8.72x | 34.92x | 1.34x | $641.34M | 1.72% | $1.08B | 8.09 | $38.81B | 41.98 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $61.98 | $16.75 | 269.94% | 63.24x | 48.55x | 6.29x | 7.87x | 1.71x | $164.23M | 3.46% | $605.69M | 7.92 | $4.59B | 41.15 | ||
| KRYS | KRYSTAL BIOTECH INC | $339.43 | $92.25 | 267.93% | 43.80x | 43.36x | 23.82x | 7.84x | 2.09x | $237.38M | 2.39% | $1.28B | 43.59 | $9.51B | 44.47 | ||
| RPRX | ROYALTY PHARMA PLC | $55.67 | $38.58 | 44.31% | 29.15x | 10.44x | 9.96x | 3.23x | 0.63x | $2.34B | 9.63% | $9.94B | 22.75 | $40.43B | 34.75 | ||
| ADMA | ADMA BIOLOGICS INC | $8.87 | $8.90 | -0.34% | 12.86x | 10.57x | 4.11x | 5.27x | 0.54x | $107.90M | 5.15% | $390.33M | 1.65 | $2.12B | 9.55 | ||
| VCEL | VERICEL CORP | $46.09 | $8.84 | 421.54% | 107.19x | 95.60x | 8.01x | 6.61x | 2.25x | $47.49M | 2.03% | $356.23M | 7.02 | $2.34B | 57.87 | ||
| HALO | HALOZYME THERAPEUTICS INC | $75.05 | $68.99 | 8.78% | 25.35x | 9.04x | 5.88x | 40.53x | 0.45x | $667.65M | 7.53% | $219.64M | 1.86 | $10.73B | 17.21 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.64 | $39.03 | 50.23% | 41.89x | 15.87x | 3.48x | 1.82x | 0.60x | $767.06M | 6.80% | $6.21B | 32.27 | $9.69B | 20.09 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $238.05 | $47.54 | 400.72% | 506.49x | 9.20x | 3.32x | 3.30x | 1.71x | $1.30B | 8.81% | $4.53B | 73.22 | $18.49B | 27.40 | ||
| ASND | ASCENDIS PHARMA A | $265.57 | $78.22 | 239.54% | 28.15x | 18.09x | 16.19x | 28.73x | 2.86x | $52.94M | 0.32% | $574.09M | 9.24 | $16.88B | 180.97 | ||
| TGTX | TG THERAPEUTICS INC | $54.89 | $20.15 | 172.34% | 17.05x | 39.49x | 11.32x | 14.41x | 4.77x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.71B | 58.07 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.81 | $34.64 | 0.49% | 13.76x | 9.54x | 2.24x | 2.21x | 0.52x | $341.79M | 16.98% | $910.35M | 15.75 | $1.58B | 6.69 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $300.97 | $91.29 | 229.70% | 38.10x | 33.16x | 21.80x | 6.05x | 1.92x | $122.22M | 2.04% | $997.32M | 50.16 | $6.37B | 28.24 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.70 | $8.69 | -80.43% | 6.30x | -5.75x | 1.59x | 1.86x | 0.08x | $7.24M | 7.41% | $52.93M | 0.92 | $44.78M | 2.89 | ||
| TECH | BIO-TECHNE CORP | $71.23 | $16.20 | 339.65% | 100.32x | 34.14x | 9.20x | 5.35x | 1.84x | $269.60M | 2.42% | $2.09B | 13.34 | $11.23B | 43.88 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $476.31 | $162.43 | 193.24% | 28.00x | 24.37x | 9.91x | 6.24x | 2.04x | $3.71B | 3.07% | $19.36B | 76.20 | $117.38B | 21.76 | ||
| UTHR | UNITED THERAPEUTICS CORP | $526.66 | $233.86 | 125.21% | 17.99x | 18.96x | 7.23x | 3.79x | 2.02x | $1.02B | 4.44% | $5.90B | 135.66 | $21.08B | 12.30 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.29 | $2.38 | 38.30% | 13.71x | 13.91x | 2.02x | 3.18x | 0.93x | $4.11M | 1.55% | $82.33M | 1.03 | $198.06M | 9.32 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.49 | $12.37 | 154.60% | 17.40x | 15.81x | 6.45x | 3.81x | 3.26x | $208.13M | 5.40% | $1.01B | 8.28 | $3.10B | 9.26 | ||
| EXEL | EXELIXIS INC | $55.77 | $30.07 | 85.45% | 17.88x | 17.14x | 6.06x | 7.24x | 1.28x | $917.69M | 6.37% | $1.94B | 7.49 | $13.96B | 13.22 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $656.12 | $421.55 | 55.64% | 15.42x | 13.94x | 4.57x | 2.19x | 1.04x | $4.11B | 6.03% | $31.42B | 302.15 | $68.53B | 11.93 | ||
| INCY | INCYTE CORP | $114.88 | $62.80 | 82.94% | 15.76x | 14.52x | 4.27x | 4.08x | 1.46x | $1.45B | 6.34% | $5.62B | 28.21 | $19.52B | 10.43 | ||
| VCYT | VERACYTE INC | $56.62 | $7.37 | 668.70% | 51.01x | 51.06x | 8.31x | 3.36x | 10.77x | $155.34M | 3.45% | $1.34B | 16.90 | $4.29B | 37.31 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.96 | $3.15 | 470.99% | 29.93x | 4.90x | 0.86x | 1.26x | 66.69x | $109.24M | 5.79% | $1.51B | 14.34 | $2.47B | 29.84 | ||
| MDXG | MIMEDX GROUP INC | $4.20 | $1.20 | 250.03% | 20.00x | -49.88x | 1.60x | 2.58x | 10.53x | $69.36M | 11.12% | $242.94M | 1.64 | $483.39M | 8.87 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.